✨ Medicines Notices




8 FEBRUARY NEW ZEALAND GAZETTE

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Methadone hydrochloride 0.2% w/v (10 mg/5 mL) Linctus Stevens Chem Industries (NZ) Limited, Pakuranga, Auckland Methaforte Linctus
Nedocromil sodium 2 mg per actuation Spray, metered dose for inhalation Fisons Plc., Holmes Chapel, Crewe, Cheshire, England and Fisons Plc., Loughborough, Leicestershire, England Tilade
Diclofenac sodium 75 mg/3 mL Injection (ampoule) Ciba-Geigy AG, Stein, Switzerland Voltaren

Dated this 31st day of January 1996.

HUGH BABER, Assistant General Manager, Health Regulation & Protection, pursuant to delegation given by the Minister of Health on 18 January 1996.

g0786

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Benzylpenicillin sodium 300 mg, 600 mg, 1.2 g, 3 g Powder for injection, vials CSL Limited, Parkville, Victoria, Australia Benpen
Prednisone 2.5 mg, 5 mg, 10 mg, 20 mg, 50 mg Tablets Upjohn Company Inc., Kalamazoo, Michigan, United States of America Deltasone
Pseudoephedrine hydrochloride 7.5 mg/0.8 mL in 15 mL Syrup Sigma Pharmaceuticals Pty Limited, Clayton, Victoria, Australia Orthoxicol for Infants Runny Nose Syrup
Pholcodine 5 mg/5 mL in 2 L Note: Not to be marketed as substitutable for any other pholcodine product as if the two (2) products were bioequivalent. Linctus Douglas Pharmaceuticals Limited, Mount Wellington, Auckland Pholcodine Linctus
Pholcodine 10 mg/5 mL in 2 L Note: Not to be marketed as substitutable for any other pholcodine product as if the two (2) products were bioequivalent. Linctus Douglas Pharmaceuticals Limited, Mount Wellington, Auckland Pholcodine Linctus (Strong)
Calcium carbonate 680 mg, magnesium carbonate heavy 80 mg Tablet Laboratoires Roche Nicholas SA., Gaillard, France Rennie
Dextromethorphan hydrobromide 15 mg, pseudoephedrine hydrochloride 30 mg in 10 mL in 100 mL, 200 mL Syrup Wyeth Australia Pty Limited, Smithfield, New South Wales, Australia Robitussin DM-P Elixir
Guaiphenesin 20 mg, pseudoephedrine hydrochloride 6 mg per mL in 100 mL, 200 mL Liquid Wyeth Australia Pty Limited, Smithfield, New South Wales, Australia Robitussin PS
Polyvinyl alcohol 1.4%, povidone 0.6% in 15 mL Eye drops Ciba Vision – Sterile Manufacturing, Mississauga, Ontario, Canada Tear Drops
Ascorbic acid 1000 mg, calcium carbonate 300 mg, calcium glycerophosphate anhydrous 327.5 mg, calcium pantothenate 25 mg, cyanocobalamin 10 mcg, nicotinamide 50 mg, pyridoxine hydrochloride 10 mg, riboflavin 15 mg, thiamine hydrochloride 15 mg Tablet Adcock Ingram Self Medication, Mobena, Republic of South Africa Vitaplus B Plus

Dated this 5th day of February 1996.

HUGH BABER, Assistant General Manager, Health Regulation and Protection, pursuant to delegation given by the Minister of Health on 18 January 1996.

g0874



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1996, No 11


NZLII PDF NZ Gazette 1996, No 11





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of Changed Medicines (continued from previous page)

πŸ₯ Health & Social Welfare
31 January 1996
Medicines Act, Changed Medicines, Health Regulation
  • Hugh Baber, Assistant General Manager, Health Regulation & Protection

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
5 February 1996
Medicines Act, New Medicines, Health Regulation
  • Hugh Baber, Assistant General Manager, Health Regulation and Protection